The cGAS–STING pathway as a therapeutic target in inflammatory diseases

Alexiane Decout(University of Warwick), Andrea Ablasser(École Polytechnique Fédérale de Lausanne)
Nature reviews. Immunology
April 8, 2021
10.1038/s41577-021-00524-z
Cited by 2,124

Related Papers

Signalling strength determines proapoptotic functions of STING
|Nature Communications|2017|497
Clathrin-associated AP-1 controls termination of STING signalling
|Nature|2022|143
The CRL5–SPSB3 ubiquitin ligase targets nuclear cGAS for degradation
|Nature|2024|54